Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme
Interventional Cardiology: Reviews, Research, Resources · 07.03.2023 · 18
DOI: 10.15420/icr.2022.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interventional Cardiology: Reviews, Research, Resources, online erschienen am 07.03.2023. Verfasst von Ahmad Edris und 9 weiteren Autor:innen. Beteiligte Einrichtung: Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background
Data on outcomes of transcatheter aortic valve replacement (TAVR) in the Middle East, particularly in the United Arab Emirates (UAE), are limited. Whether centres with a low volume of patients requiring the procedure can achieve similar outcomes as those reported in pivotal clinical trials remains unclear. This study evaluates procedural outcomes of patients undergoing TAVR in a newly established programme in the UAE.
Methods
Procedural outcomes of consecutive patients who underwent transfemoral TAVR at a single centre in the UAE between January 2016 and November 2021 were compared with those at centres in the lowest quartile (Q1) of procedural volume in the Transcatheter Valve Therapy Registry, which covers centres in the US.
Results
Among the 183 patients included in the study, the median age was 76 years (interquartile range [IQR] 71–82), and 42.1% of patients were women, with a median Society of Thoracic Surgeons predicted risk of mortality score of 4.6 (IQR 2.9–7.5). Most of the patients (93.3%) received a balloon expandable valve. All-cause death within 30 days, stroke and major vascular complications occurred in 0.6%, 0.6% and 2.2% of patients, respectively, compared with 3.1%, 2.2% and 4% in patients treated at Q1 hospitals.
Conclusion
Patients undergoing transfemoral TAVR at an emerging centre in the Middle East had favourable outcomes compared with those performed at Q1 hospitals in the US. These findings suggest that careful patient selection for TAVR is critical and may help optimise patient outcomes, especially when procedural volumes are low.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates.
Zitieren
APA
Edris, A., Manla, Y., Al Badarin, F., Hasan, K., Hashmani, S., Traina, M., Khiati, D., Khalouf, A., El Zouhbi, A., & Tuzcu, E. M. (2023). Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme. Interventional Cardiology: Reviews, Research, Resources, 18. https://doi.org/10.15420/icr.2022.04
Vancouver
Edris A, Manla Y, Al Badarin F, Hasan K, Hashmani S, Traina M, et al. Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme. Interventional Cardiology: Reviews, Research, Resources. 2023;18. doi:10.15420/icr.2022.04
BibTeX
@article{Edris2023,
author = {Edris, Ahmad and Manla, Yosef and Al Badarin, Firas and Hasan, Khwaja and Hashmani, Shahrukh and Traina, Mahmoud and Khiati, Dhiaedin and Khalouf, Amani and El Zouhbi, Anas and Tuzcu, Emin Murat},
title = {Outcomes of Transcatheter Aortic Valve Replacement in the United Arab Emirates: Real-world, Single-centre Experience from an Emerging Programme},
journal = {Interventional Cardiology: Reviews, Research, Resources},
year = {2023},
volume = {18},
doi = {10.15420/icr.2022.04}
}
EUVIMED